New cancer drug candidate tested for drug interactions
NCT ID NCT06919991
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested how the experimental drug casdatifan interacts with two common medications in 14 healthy adults. Participants received casdatifan alone and then with itraconazole or phenytoin to see how these drugs affect casdatifan levels in the body. The goal was to gather safety and drug-processing information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- casdatifan
- What this could lead to
- If successful, this study could help determine the right dosing of casdatifan when taken with other medications, supporting future trials.
- What could go wrong
- This is a very early, small study in healthy volunteers, not patients. It only looks at drug levels and safety, not whether casdatifan works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Celerion
Tempe, Arizona, 85283, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates